---
title: "linagliptin - Diabetes mellitus type 2"
sidebar: mydoc_sidebar
permalink: linagliptindiabetesmellitustype22.html
toc: false 
---

{% include image.html file="linagliptindiabetesmellitustype22.png" alt="linagliptindiabetesmellitustype22" %}![Path Visualization](/images/linagliptindiabetesmellitustype22.png)

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D000069476 | linagliptin | Drug |
| UniProt:P27487 | DPP-4 | Protein |
| UniProt:P01275 | glucagon-like peptide 1 | Protein |
| UniProt:P01275 | glucagon | Protein |
| MESH:D006003 | glycogen | ChemicalSubstance |
| MESH:D005947 | glucose | ChemicalSubstance |
| MESH:D003924 | Diabetes mellitus type 2 | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Linagliptin | DECREASES ACTIVITY OF | Dpp-4 |
| Dpp-4 | INCREASES ACTIVITY OF | Glucagon |
| Glucagon | DECREASES ACTIVITY OF | Glucagon |
| Glucagon | DECREASES ABUNDANCE OF | Glycogen |
| Glycogen | DECREASES ABUNDANCE OF | Glucose |
| Glucose | TREATS | Diabetes Mellitus Type 2 |
|---------|-----------|---------|

Reference: [https://go.drugbank.com/drugs/DB:DB08882#mechanism-of-action](https://go.drugbank.com/drugs/DB:DB08882#mechanism-of-action){:target="_blank"}